Tempus AI Acquires Personalis for $1.5 Billion

Tempus AI has acquired Personalis, a cancer-monitoring firm, for $1.5 billion in a deal focused on precision oncology. This acquisition aims to enhance Tempus AI's capabilities in cancer diagnostics and treatment.